Feist, Eugen
Mitrovic, Stéphane
Fautrel, Bruno
Article History
First Online: 14 September 2018
Competing interests
: E.F. has received consultant fees from AbbVie, Biogen, BMS, Celgene, Janssen, Lilly, Medac, MSD, Nordic Pharma, Novartis, Pfizer, Roche, Sanofi-Aventis, Swedish Orphan Biovitrum and UCB, as well as research grants from BMS, Lilly, Novartis, Pfizer and Roche. S.M. has received consultant fees from BMS and Pfizer. B.F. has received consultant fees from AbbVie, Biogen, BMS, Celgene, Janssen, Lilly, Medac, MSD, Nordic Pharma, Novartis, Pfizer, Roche, Sanofi-Aventis, Swedish Orphan Biovitrum and UCB, as well as research grants from AbbVie, MSD and Pfizer.